EyePoint Pharmaceuticals EYPT

$ 8.4 -6.2%

Quarterly report 2024-Q3
added 11-07-2024

EyePoint Pharmaceuticals Total Shareholders Equity 2011-2024 | EYPT

Annual Total Shareholders Equity EyePoint Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
266 M	96.4 M	184 M	18.5 M	8.33 M	37.6 M	13.3 M	20.9 M	23.4 M	14.9 M	7.7 M	13.6 M	37.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
266 M	7.7 M	57.1 M

Quarterly Total Shareholders Equity EyePoint Pharmaceuticals

2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
219 M	228 M	266 M	58.6 M	57.3 M	78.4 M	96.4 M	136 M	151 M	167 M	184 M	92.7 M	107 M	116 M	18.5 M	18.5 M	18.5 M	18.5 M	8.33 M	8.33 M	8.33 M	8.33 M	37.6 M	37.6 M	37.6 M	37.6 M	9.9 M	9 M	9.9 M	9 M	14.8 M	14.3 M	14.8 M	14.4 M	14.4 M	18.8 M	14.4 M	18.8 M	32.3 M	35.8 M	32.3 M	14.9 M	12.6 M	14.2 M	7.7 M	7.7 M	13.8 M	16.2 M	13.6 M	13.6 M	17.8 M	35.2 M	37.4 M	37.4 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
266 M	7.7 M	50.4 M